Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial
- 31 July 2010
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 160 (1), 16-22.e1
- https://doi.org/10.1016/j.ahj.2010.04.022
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Cytochrome P450 Genetic Polymorphisms and the Response to PrasugrelCirculation, 2009
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelThe New England Journal of Medicine, 2009
- Prasugrel: A Novel Thienopyridine Antiplatelet Agent. A Review of Preclinical and Clinical Studies and the Mechanistic Basis for Its Distinct Antiplatelet ProfileCardiovascular Drug Reviews, 2007
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2007
- Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA TrialJournal of the American College of Cardiology, 2007
- Aspirin and clopidogrel resistance: an emerging clinical entityEuropean Heart Journal, 2005
- Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary SyndromeCirculation, 2004
- A Validated Prediction Model for All Forms of Acute Coronary SyndromeJAMA, 2004
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionThe New England Journal of Medicine, 1993
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982